STOCK TITAN

GRAIL to Participate in Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

GRAIL (Nasdaq: GRAL) has announced its participation in two upcoming investor conferences. The company will conduct fireside chats at the Piper Sandler 36th Annual Healthcare Conference in New York on December 3 at 1:30 p.m. ET, and at the 7th Annual Evercore ISI HealthCONx Conference in Coral Gables, Florida on December 4 at 3:50 p.m. ET. Both sessions will be available via webcast on GRAIL's investor relations website, with replays accessible for at least 30 days following the events.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

+2.03% News Effect

On the day this news was published, GRAL gained 2.03%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

MENLO PARK, Calif., Nov. 19, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will participate in the following investor conferences.

  • Piper Sandler 36th Annual Healthcare Conference in New York, NY: fireside chat on Tuesday, Dec. 3 at 1:30 p.m. ET
  • 7th Annual Evercore ISI HealthCONx Conference in Coral Gables, Fla.: fireside chat on Wednesday, Dec. 4 at 3:50 p.m. ET

Live and replay webcasts may be accessed in the investor relations section of GRAIL's website at investors.grail.com. The webcast will be archived and available for reply for at least 30 days after the event.

About GRAIL
GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. GRAIL's targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. GRAIL is headquartered in Menlo Park, CA with locations in Washington, D.C., North Carolina, and the United Kingdom.
For more information, visit grail.com.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/grail-to-participate-in-upcoming-investor-conferences-302310482.html

SOURCE GRAIL, Inc.

FAQ

When is GRAIL (GRAL) presenting at the Piper Sandler Healthcare Conference 2024?

GRAIL (GRAL) will present at the Piper Sandler Healthcare Conference on December 3, 2024, at 1:30 p.m. ET in New York.

Where can I watch GRAIL's (GRAL) investor conference webcasts?

GRAIL's investor conference webcasts can be accessed through the investor relations section of GRAIL's website at investors.grail.com, with replays available for 30 days after each event.

What investor conferences is GRAIL (GRAL) attending in December 2024?

GRAIL is attending the Piper Sandler 36th Annual Healthcare Conference in New York and the 7th Annual Evercore ISI HealthCONx Conference in Coral Gables, Florida.

What time is GRAIL's (GRAL) presentation at the Evercore ISI HealthCONx Conference?

GRAIL will present at the Evercore ISI HealthCONx Conference on December 4, 2024, at 3:50 p.m. ET in Coral Gables, Florida.
Grail Inc

NASDAQ:GRAL

GRAL Rankings

GRAL Latest News

GRAL Latest SEC Filings

GRAL Stock Data

3.82B
35.08M
13.81%
73.53%
13.42%
Diagnostics & Research
Services-medical Laboratories
Link
United States
MENLO PARK